Homocysteine(Hcy) has been implicated as a novel risk factor of Coronary Artery Disease (CAD) among Asian Indians, but many studies done in India failed to reveal any direct correlation. It has also been reported that Folic acid and Vitamin B12 levels inversely affect serum levels of homocysteine. In this study, we looked at the levels of homocysteine among patients with CAD. The effect of Vitamin B12, Folate and other risk factors on homocysteine levels were also evaluated. Mean homocysteine levels in cases (22.81 ± 13.9, n=70) were significantly higher (p=< 0.001) than the controls (7.77 ± 7.3, n=70). However no statistically significant correlation could be deduced between homocysteine, Vitamin B12, and Folate. Cumulative analysis have indicated an increase in homocysteine levels among patients with CAD with every additional risk factor.
INTRODUCTION
Atherosclerotic disease involving coronary, peripheral and cerebrovascular system continues to be a major health problem in adult population, both in developed and developing countries. Control of conventional risk factors (e.g. smoking, lipids, etc.) has brought a decline in incidence of coronary artery disease (CAD) in developed countries. However, despite aggressive control of risk factors in the general population, it is not possible to prevent progression of CAD in all patients. Homocysteine recently has been recognized as a risk factor for the presence of atherosclerotic vascular disease and hypercoagulability states (1).
Homocysteine (tHcy or H (e)) is the term used to describe the combination of homocysteine, homocystine, homocysteine thiolactone, and homocysteine mixed disulfides in the serum. Elevation of plasma tHcy is multifactorial: increased dietary intake, heritable enzyme deficiencies, and vitamin cofactor deficiencies all play a role (2).
The two pathways which metabolize Homocysteine, (a sulfhydryl amino acid),are trans-sulfuration and remethylation. When excess homocysteine is present in the blood, a major by-product is formed which is homocysteine thiolactone, which reacts with lowdensity lipoprotein (LDL) to form LDL-homocysteine thiolactone aggregates. These are taken up by macrophages and subsequently incorporated into foam cells in early atherosclerotic plaques. Within these plaques, homocysteine thiolactone acylates proteins and modifies the oxidative processes of the vessel, thereby promoting atherothrombosis. In addition, auto-oxidation of homocysteine results in the formation of superoxide and hydrogen peroxide. These oxygen-derived molecules may contribute to oxidation of LDL and endothelial dysfunction and promote proliferation of vascular smooth muscle cells.
Many studies have been done on the role of homocysteine as an independent risk factor. Moderately high levels of plasma homocysteine are associated with subsequent risk of myocardial infarction independent of other coronary risk factors (3) . A two fold increase in likelihood of myocardial infarction among persons with a total homocysteine concentration more than or equal to 15 micromol/Liter has been noted in a national representative survey in the United States (4). High plasma homocysteine, low folate and vitamin B12 are associated with increased risk of extracranial carotid artery stenosis in the elderly (5) . It is also found to be an independent risk factor for stroke (6) . High plasma homocysteine levels are a risk factor for deep vein thrombosis in the general population (7) . The thrombogenic mechanism of homocysteine was revealed by the relative involvement of platelets, coagulation and fibrinolytic agents and by characterization of the vascular effects of homocysteine infusion in primate model (8) .
Age, gender, folate, Vit B12, serum Creatinine and multivitamin usage are all important determinants of the plasma homocysteine concentration, whereas only age and serum Creatinine are determinants of the plasma cysteine concentration. The age related increase in homocysteine and cysteine may be linked to the age related impairment of renal function, where as the sex difference in plasma homocysteine may be because of the fact that more homocysteine is formed in men than in women in conjunction with creatinecreatinine synthesis (9) . It has been shown that high plasma homocysteine levels can be reversed with vitamin supplements (10) . Plasma total levels are a strong predictor of mortality in patients with angiographically confirmed coronary artery disease (11) .
Correlative studies on homocysteine, folate and vitamin B12 in Asian Indians are sparse and controversy exists in this matter. In a case controlled study with 551 cases (294 Europeans and 257 Asian Indians), Asian Indians with CAD and elevated homocysteine levels had a 40% higher mortality as compared to Europeans (12) . At the same time, smaller studies conducted in India did not show any significant difference in the homocysteine levels (13, 14) . The objective of our study was to evaluate serum homocysteine levels in patients with coronary artery disease and analyze the effects of Vit B12, folate and other risk factors on these level.
MATERIALS AND METHODS
This was a prospective study of 70 cases and 70 controls. Cases included patients presenting to the Intensive Coronary Care Unit of Christian Medical College and Hospital Ludhiana with Acute Coronary syndromes. They included Acute Myocardial Infarction, Non Q Myocardial Infarction and Unstable Angina.
Control Group : Age and sex matched healthy individuals without clinical evidence of coronary artery disease and with normal ECG constituted the control group.
Study group : All diagnosed cases of acute coronary syndromes made according to the standard diagnostic criteria (15) were included in the study group.
Exclusion Criteria : Subjects with renal failure (Crt >/= 3.0gm/dl), hepatic dysfunction, pregnancy, hypothyroidism, and those taking Methotrexate, Carbamazepine or phenytoin were excluded from the study.
Clinical assessment : On admission, clinical examination was done. Detailed history was taken regarding the duration, frequency and severity of chest pain, exercise tolerance, presence of coronary risk factors and history of previous Myocardial Infarction. A detailed examination was done to find out the presence or absence of cardiac failure and or presence of associated cardiac lesion. A 12-lead ECG recording was taken and blood samples were taken for the relevant investigations.
Homocysteine estimation : 5-10 ml of blood was collected for serum separation and transported to the laboratory. Centrifugation and separation were done at the earliest and samples were stored at -20 degree Celsius till they were analyzed.
Assay principle : Homocysteine was measured using a solid phase immunoassay system, which measures total homocysteine in plasma or serum (BioRad). Protein bound homocysteine was reduced to free homocysteine and enzymatically converted to Sadenosyl-L-homocysteine (SAH) in a separate procedure prior to the immunoassay (16) . A Reference value of 5-15micromol/L was considered for adult male and female.
Vitamin B12 and Folate Estimation : Serum Vitamin B12 and Folate were simultaneously determined using a radio-Immuno assay kit. (ICN) . A reference value of 160-970pg/ml for Vitamin B12 and 3.0-17ng/ml for folic acid were considered.
Statistical analysis : Data was analyzed using Mann Whitney U test for paired samples, and Kruskal Wallis test for discrete variables to find out the statistical differences between the two groups. A 'p' value was subsequently calculated and significance fixed at 0.05 or less.
RESULTS
A total of 140 patients were enlisted for the study. Seventy patients with a diagnosis of acute coronary syndrome admitted to the intensive coronary care unit of CMC & H, Ludhiana, were taken up as cases. The control group included seventy individuals who were otherwise healthy, having no evidence of any cardiac disease on history and on examination and having a normal electrocardiogram. The difference in the mean age and the number of males and females in the two groups were statistically not significant. (Table 1) .
Homocysteine levels were significantly higher among cases (22.81±13.9 mo/L) as compared to the controls (7.77±7.3 mo/L) ( Table 1) .
Pooled cases and controls whose B12 levels were less than 160 pg/ml had higher mean homocysteine levels than patients whose B12 was adequate. An inverse correlation between Vitamin B12 and homocysteine levels was observed. Although homocysteine levels seemed to decrease as B12 levels increased, they were not statistically significant probably due to smaller numbers ( Table 2) . Serum homocysteine levels of pooled cases and controls were correlated with folate levels in serum.
The mean homocysteine levels of the group with serum folate </= 3ng/ml was 19.98 ± 21.87 mo/L, and of the group >3ng/ml was 15.08 ±13.06 mo/L. Patients with CAD having low levels of folate had higher homocysteine levels as compared to those having adequate folate levels. On comparing both the means, p value was not significant (Table 3) .
Homocysteine values were compared with the vegetarians and non-vegetarians among study group and control groups. The mean homocysteine among the vegetarians were 14.42 ± 12.23 mo/L and that of non-vegetarians were 16.33 ± 14.83 mo/L. There A subgroup analysis of cumulative risk factors were done, which showed that the homocysteine levels were 20.46 ± 10.44 mo/L in patients with no risk factors, a level lower than the all the cases put together 22.81 ± 13.9 mo/L. However, with every additional risk factor, the homocysteine levels increased. With CAD along with one risk factor (either diabetes, HTN, Smoking or Hyperlipidemia, the homocysteine level was (n=27) 21.67 ± 9.58 . When coupled with 2 risk factors, it was (n=24)23.43 ± 18.79. Subsequent addition of one more risk factor (3 risk factors), the homocysteine level was (n=10) 23.92 ± 13.34. With all the risk factors put together, there was only one case and Hcy level was 46.7. However, on analyzing all the groups with non parametric statistical analysis, there was no statistically significant difference (Table 4) .
DISCUSSION
Homocysteine has been recently identified as a novel risk factor for coronary artery disease. It was in 1969, Mc Cully made the first correlation between high plasma homocysteine and vascular disease (17) . Later in 1976, Wilken et al published the first report that patients with coronary artery disease have abnormal homocysteine metabolism (18) . After 1990, many publications implicated elevated plasma homocysteine as an independent risk factor. In 1992 the first ever-positive prospective study was made on plasma homocysteine as a risk of myocardial infarction among the physicians in United States (3) . Another study in UK established that the plasma homocysteine concentrations were higher among Asian Indians and higher fasting homocysteine levels increased the mortality of the patients (12) . Although studies conducted in India (13, 14, 19) , did not show increased homocysteine levels among patients with coronary artery disease, our study was consistent with the western studies (3, 12) .
Mishra et al in their study of an urban population of N India have observed an association between hyperhomocysteinaemia and low intake of folate and vit B12 (20) . In our study, although there is an apparent correlation between low folate and high homocysteine, the values were not statistically significant (Table 3) . There are many studies, which shows higher homocysteine levels with low intake of vitamin B12 (20, 21, 22) . In our study, there is an inverse correlation between homocysteine and vitamin B12 which is statistically not significant (Table 2 ). This may be because of less number of patients.
Dietary deficiency or disorders related to folate and B12 malabsorption lead to hyperhomocysteinaemia and an increased risk of CAD (23) In a review in 2002, on the role of nutritional supplementation in reducing the levels of homocysteine, they suggested that in Indian population, apart from low dietary folate intake, the intake of riboflavin, Vitamin B12 and Vitamin B6 are also low compared to the western population (24) . On the other hand, there are other studies, which mentioned the "Indian dietary paradox". The assumption is that many Indians by virtue of their vegetarian diet do receive fairly adequate amounts of folate. In that case, the reasons for this paradox is prolonged cooking, heating, frying etc of vegetables (which is a common practice among Indian households) which can destroy upto 90% of the folate content of vegetables (25, 26) . In our study, there was no statistically significant difference (p= 0.768) in homocysteine levels among vegetarians(14.42 ± 12.23, n=76) and non-vegetarians (16.33 ± 14.83 n=64). A number of studies have shown a correlation between hyperhomocysteinaemia and hypertension (27, 28) . Varied results were observed among diabetics as well. Munshi et al. (29) demonstrated elevated homocysteine levels in non-insulin dependent diabetic subjects compared to age matched controls. and Hoffman et al. (30) reported that hyperthomocysteinaemia is more common in type 1 diabetic patients with nephropathy. Deepa et al. (19) did not reveal any significant increase of homocysteine levels in diabetes per se or in diabetic patients with CAD. In the Hordaland study in Norway, increasing plasma levels of cholesterol, triglycerides and smoking were associated with increasing levels of homocysteine (11) . Among secondary causes of hyyperthomocysteinaemia, smoking plays an important role by interfering with the synthesis of pyridoxal phosphate (11) , which is important for the conversion of homocysteine to cystathione by the enzyme Cystathione b synthase. On doing cumulative analysis (Table 4) , the homocysteine levels were lower among patients with CAD without risk factors as compared to the overall value among cases.
We have observed that there is an apparent increase in homocysteine levels among patients with CAD as the number of risk factor increases. However this is not statistically significant. Analysis of a larger group would definitely give us an insight into the various causative factors leading to hyperhomocysteinaemia and its role in CAD amongst the Indian population. 
